Hbk Sorce Advisory LLC Pfizer Inc Transaction History

Hbk Sorce Advisory LLC

  • $2.69 Billion
  • Q2 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 135,558 shares of PFE stock, worth $4.03 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
135,558
Previous 126,540 7.13%
Holding current value
$4.03 Million
Previous $3.51 Million 8.0%
% of portfolio
0.14%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$25.26 - $29.6 $227,794 - $266,932
9,018 Added 7.13%
135,558 $3.79 Million
Q1 2024

May 09, 2024
BUY
$25.89 - $29.73 $164,841 - $189,290
6,367 Added 5.3%
126,540 $3.51 Million
Q4 2023

Jan 25, 2024
SELL
$26.13 - $33.94 $250,534 - $325,416
-9,588 Reduced 7.39%
120,173 $3.46 Million
Q3 2023

Nov 06, 2023
BUY
$32.09 - $37.51 $92,098 - $107,653
2,870 Added 2.26%
129,761 $4.3 Million
Q2 2023

Aug 04, 2023
SELL
$36.12 - $41.79 $5.15 Million - $5.96 Million
-142,687 Reduced 52.93%
126,891 $4.65 Million
Q1 2023

Aug 15, 2023
SELL
$39.39 - $51.28 $632,682 - $823,659
-16,062 Reduced 12.66%
110,829 $4.52 Million
Q1 2023

May 15, 2023
SELL
$39.39 - $51.28 $69,483 - $90,457
-1,764 Reduced 0.65%
269,578 $16.6 Million
Q4 2022

Feb 09, 2023
BUY
$41.75 - $54.5 $6.33 Million - $8.27 Million
151,706 Added 126.81%
271,342 $13.9 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $53.42 $1.78 Million - $2.17 Million
40,713 Added 51.59%
119,636 $5.24 Million
Q2 2022

Aug 15, 2022
SELL
$46.53 - $55.17 $2.16 Million - $2.56 Million
-46,468 Reduced 37.06%
78,923 $4.14 Million
Q1 2022

May 13, 2022
SELL
$45.75 - $56.69 $564,189 - $699,101
-12,332 Reduced 8.95%
125,391 $6.49 Million
Q4 2021

Feb 15, 2022
SELL
$41.32 - $61.25 $35,576 - $52,736
-861 Reduced 0.62%
137,723 $8.13 Million
Q3 2021

Nov 15, 2021
SELL
$39.25 - $50.42 $648,292 - $832,787
-16,517 Reduced 10.65%
138,584 $5.96 Million
Q2 2021

Aug 12, 2021
BUY
$35.91 - $40.68 $883,242 - $1 Million
24,596 Added 18.85%
155,101 $6.07 Million
Q1 2021

May 14, 2021
BUY
$33.49 - $37.77 $71,601 - $80,752
2,138 Added 1.67%
130,505 $4.73 Million
Q4 2020

Feb 12, 2021
BUY
$33.47 - $42.56 $353,777 - $449,859
10,570 Added 8.97%
128,367 $4.73 Million
Q3 2020

Nov 13, 2020
BUY
$31.75 - $37.25 $120,967 - $141,922
3,810 Added 3.34%
117,797 $4.32 Million
Q2 2020

Aug 14, 2020
BUY
$30.12 - $36.54 $193,099 - $234,257
6,411 Added 5.96%
113,987 $3.73 Million
Q1 2020

May 15, 2020
SELL
$27.03 - $38.62 $152,043 - $217,237
-5,625 Reduced 4.97%
107,576 $3.51 Million
Q4 2019

Feb 13, 2020
BUY
$32.92 - $37.36 $298,781 - $339,079
9,076 Added 8.72%
113,201 $4.44 Million
Q3 2019

Nov 14, 2019
BUY
$32.49 - $42.13 $81,289 - $105,409
2,502 Added 2.46%
104,125 $3.74 Million
Q2 2019

Aug 15, 2019
BUY
$36.98 - $41.52 $1 Million - $1.13 Million
27,166 Added 36.49%
101,623 $4.4 Million
Q2 2019

Aug 14, 2019
SELL
$36.98 - $41.52 $828,241 - $929,923
-22,397 Reduced 23.12%
74,457 $2.62 Million
Q1 2019

May 13, 2019
BUY
$37.5 - $41.2 $26,512 - $29,128
707 Added 0.74%
96,854 $4.11 Million
Q4 2018

Feb 14, 2019
BUY
$38.47 - $43.86 $62,744 - $71,535
1,631 Added 1.73%
96,147 $4.2 Million
Q3 2018

Nov 15, 2018
SELL
$34.47 - $41.81 $49,154 - $59,621
-1,426 Reduced 1.49%
94,516 $4.17 Million
Q2 2018

Aug 10, 2018
SELL
$32.98 - $35.16 $132,612 - $141,378
-4,021 Reduced 4.02%
95,942 $0
Q1 2018

May 15, 2018
BUY
$31.91 - $37.02 $242,643 - $281,500
7,604 Added 8.23%
99,963 $3.55 Million
Q4 2017

Feb 15, 2018
BUY
$33.26 - $35.29 $728,759 - $773,239
21,911 Added 31.1%
92,359 $3.35 Million
Q3 2017

Nov 14, 2017
BUY
$31.0 - $34.15 $2.18 Million - $2.41 Million
70,448
70,448 $2.52 Million

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email